Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Pharma
Lilly to beef up injectables production with Nexus plant in WI
Eli Lilly is paying an undisclosed sum to acquire Nexus Pharmaceuticals’ high-tech injectable production facility in Pleasant Prairie, Wisconsin.
Fraiser Kansteiner
Apr 23, 2024 3:07pm
Eli Lilly's Mounjaro, Zepbound supply outlook worsens
Apr 18, 2024 10:22am
Eli Lilly's tirzepatide excels in phase 3 sleep apnea studies
Apr 17, 2024 11:04am
Demand for Lilly's Zepbound triggers US supply constraints
Mar 29, 2024 1:14pm
Lilly flags impurity concerns in fake versions of GLP-1 drugs
Mar 7, 2024 4:00pm
The FDA cracks down with a trio of pharma warning letters
Feb 14, 2024 8:15am